Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders

In recent years, the exploration of regulatory T cell (Treg)-based cellular therapy has become an attractive strategy to ameliorate inflammation and autoimmunity in various clinical settings. The main obstacle to the clinical application of Treg in human is their low number circulating in peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiesinger, Manuel, Stoica, Diane, Roessner, Susanne, Lorenz, Carmen, Fischer, Anika, Atreya, Raja, Neufert, Clemens F., Atreya, Imke, Scheffold, Alexander, Schuler-Thurner, Beatrice, Neurath, Markus F., Schuler, Gerold, Voskens, Caroline J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662555/
https://www.ncbi.nlm.nih.gov/pubmed/29123521
http://dx.doi.org/10.3389/fimmu.2017.01371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662555/
https://www.ncbi.nlm.nih.gov/pubmed/29123521
http://dx.doi.org/10.3389/fimmu.2017.01371

Ejemplares similares